PMID- 27434868 OWN - NLM STAT- MEDLINE DCOM- 20170207 LR - 20170809 IS - 1950-6007 (Electronic) IS - 0753-3322 (Linking) VI - 83 DP - 2016 Oct TI - Periostin mediates cigarette smoke extract-induced proliferation and migration in pulmonary arterial smooth muscle cells. PG - 514-520 LID - S0753-3322(16)30364-X [pii] LID - 10.1016/j.biopha.2016.07.007 [doi] AB - Cigarette smoking is an important risk factor for pulmonary arterial hypertension (PAH). Pulmonary arterial smooth muscle cells (PASMCs) play a critical role in the pathogenesis of PAH-associated arterial remodeling. This study was done to explore the expression and biological roles of periostin in PASMCs following exposure to cigarette smoke extract (CSE). PASMCs were exposed to different concentrations of CSE and tested for gene expression and reactive oxygen species (ROS) production. PASMCs were incubated with recombinant periostin protein or transfected with small interfering RNA targeting periostin before CSE exposure and then examined for cell proliferation and migration. Compared to control cells, exposure to CSE led to a significant upregulation of periostin. Pretreatment with 5mM N-acetyl-l-cysteine (an inhibitor of ROS formation) or 10muM U0126 (an inhibitor of ERK1/2) significantly prevented the induction of periostin in CSE-treated PASMCs. The addition of recombinant periostin protein significantly enhanced the proliferation and migration of PASMCs. In contrast, knockdown of endogenous periostin counteracted the proliferation and migration of PASMCs induced by CSE treatment. In conclusion, CSE induces the expression of periostin in PASMCs via promotion of ROS and activation of ERK1/2. Periostin mediates the effects of CSE on PASMC proliferation and migration. These findings warrant further exploration of the roles of periostin in cigarette smoking-associated pulmonary arterial remodeling. CI - Copyright (c) 2016 Elsevier Masson SAS. All rights reserved. FAU - Wang, Xiao-Dong AU - Wang XD AD - Department of Respiratory Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. FAU - Li, Fang AU - Li F AD - Department of Respiratory Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. FAU - Ma, Dong-Bo AU - Ma DB AD - Department of Respiratory Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. FAU - Deng, Xiang AU - Deng X AD - Department of Respiratory Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. FAU - Zhang, Hui AU - Zhang H AD - Department of Respiratory Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. FAU - Gao, Jia AU - Gao J AD - Department of Respiratory Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. FAU - Hao, Li AU - Hao L AD - Department of Respiratory Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. FAU - Liu, Dan-Dan AU - Liu DD AD - Department of Respiratory Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. FAU - Wang, Jing AU - Wang J AD - Department of Respiratory Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Electronic address: drjingwang@qq.com. LA - eng PT - Journal Article DEP - 20160718 PL - France TA - Biomed Pharmacother JT - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie JID - 8213295 RN - 0 (Cell Adhesion Molecules) RN - 0 (POSTN protein, human) RN - 0 (Reactive Oxygen Species) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) SB - IM MH - Cell Adhesion Molecules/*metabolism MH - *Cell Movement MH - Cell Proliferation MH - Extracellular Signal-Regulated MAP Kinases/metabolism MH - Gene Knockdown Techniques MH - Humans MH - Myocytes, Smooth Muscle/*metabolism/*pathology MH - Pulmonary Artery/*pathology MH - Reactive Oxygen Species/metabolism MH - *Smoking MH - Up-Regulation OTO - NOTNLM OT - Cigarette smoke OT - Migration OT - Proliferation OT - Smooth muscle cells OT - Vascular remodeling EDAT- 2016/10/25 06:00 MHDA- 2017/02/09 06:00 CRDT- 2016/07/20 06:00 PHST- 2016/03/24 00:00 [received] PHST- 2016/07/03 00:00 [revised] PHST- 2016/07/03 00:00 [accepted] PHST- 2016/10/25 06:00 [pubmed] PHST- 2017/02/09 06:00 [medline] PHST- 2016/07/20 06:00 [entrez] AID - S0753-3322(16)30364-X [pii] AID - 10.1016/j.biopha.2016.07.007 [doi] PST - ppublish SO - Biomed Pharmacother. 2016 Oct;83:514-520. doi: 10.1016/j.biopha.2016.07.007. Epub 2016 Jul 18.